Two-year changes of macular choroidal thickness in response to 0.01% atropine eye drops: Results from the myopia outcome study of atropine in children (MOSAIC) clinical trial.
dc.contributor.author | Kobia-Acquah, Emmanuel | |
dc.contributor.author | Lingham, Gareth | |
dc.contributor.author | Flitcroft, Daniel Ian | |
dc.contributor.author | Loughman, James | |
dc.date.accessioned | 2025-01-10T09:47:07Z | |
dc.date.available | 2025-01-10T09:47:07Z | |
dc.date.issued | 2024-12-29 | |
dc.identifier.pmid | 39737658 | |
dc.identifier.pmid | 39737658 | |
dc.identifier.doi | 10.1111/aos.17429 | |
dc.identifier.uri | http://hdl.handle.net/10147/643873 | |
dc.language.iso | en | en_US |
dc.rights | © 2024 The Author(s). Acta Ophthalmologica published by John Wiley & Sons Ltd on behalf of Acta Ophthalmologica Scandinavica Foundation. | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | atropine | en_US |
dc.subject | Children | en_US |
dc.subject | choroidal thickness | en_US |
dc.subject | myopia | en_US |
dc.subject | randomised controlled trial | en_US |
dc.title | Two-year changes of macular choroidal thickness in response to 0.01% atropine eye drops: Results from the myopia outcome study of atropine in children (MOSAIC) clinical trial. | en_US |
dc.type | Article | en_US |
dc.identifier.eissn | 1755-3768 | |
dc.identifier.journal | Acta ophthalmologica | en_US |
dc.source.journaltitle | Acta ophthalmologica | |
refterms.dateFOA | 2025-01-10T09:47:08Z | |
dc.source.country | England |